TA
GILD icon

TFB Advisors’s Gilead Sciences GILD Stock Holding History

TFB Advisors’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$316K Buy
2,498
+93
+4% +$12.3K 0.14% 153
2026
Q1 		$335K Sell
2,405
-386
-14% -$54.1K 0.18% 135
2025
Q4 		$343K Sell
2,791
-35
-1% -$4.25K 0.1% 227
2025
Q3 		$335K Sell
2,826
-1,531
-35% -$174K 0.1% 225
2025
Q2 		$483K Buy
4,357
+80
+2% +$8.51K 0.13% 185
2025
Q1 		$479K Sell
4,277
-164
-4% -$16.9K 0.14% 173
2024
Q4 		$410K Sell
4,441
-4,956
-53% -$446K 0.12% 196
2024
Q3 		$788K Buy
9,397
+116
+1% +$8.85K 0.23% 100
2024
Q2 		$637K Sell
9,281
-1,274
-12% -$85K 0.21% 107
2024
Q1 		$691K Buy
10,555
+3,534
+50% +$272K 0.25% 92
2023
Q4 		$569K Buy
+7,021
New +$546K 0.29% 82
2023
Q3 		– Sell
-11,499
Closed -$886K – 144
2023
Q2 		$886K Buy
11,499
+6,684
+139% +$533K 0.39% 64
2023
Q1 		$400K Buy
4,815
+372
+8% +$30.8K 0.3% 65
2022
Q4 		$381K Buy
+4,443
New +$352K 0.32% 63

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

TFB Advisors's GILD Position: Q2 2026 in Review

TFB Advisors increased its Gilead Sciences (GILD) stake by 3.9% in Q2 2026, buying an estimated $12.3K and bringing the position to 2,498 shares worth $316K. The position accounts for 0.14% of the portfolio, ranked #153.

TFB Advisors first reported a position in GILD in Q4 2022 and has held it in 14 quarters since. The position peaked at $886K in Q2 2023. 2,283 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • TFB Advisors held 2,498 shares of Gilead Sciences worth $316K as of Q2 2026.
  • TFB Advisors bought 93 Gilead Sciences shares in Q2 2026, an estimated $12.3K.
  • Gilead Sciences made up 0.14% of TFB Advisors's portfolio in Q2 2026, its #153 holding.
  • TFB Advisors first reported a position in Gilead Sciences in Q4 2022 and has held it in 14 quarters since.
  • TFB Advisors's Gilead Sciences position peaked at $886K in Q2 2023.
  • 2,283 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on TFB Advisors's 13F filing for Q2 2026, filed 6 Aug 2026.